Eli Lilly posts best-ever weight-loss data

· Health · United States

Endpoints Weekly reported that Eli Lilly delivered its best-ever weight-loss data, in a week that also brought several prominent pharma deals. Among them, Sanofi and Regeneron re-upped with $1 billion upfront.

Why it matters：New weight-loss data and pharma deals highlight the sector's focus on obesity treatments and pipeline value.

Key points

  • Endpoints described the weight-loss data as Lilly's best ever.
  • Sanofi and Regeneron re-upped for $1 billion upfront.
  • The roundup said the week featured a number of prominent deals.

Sources (original reporting)

More stories from this day